Navigation Links
Rajasthan Doctors Booked For Female Foeticide

The Rajasthan government has filed police complaints against 21 doctors alleged to have been involved in the practice of female foeticide.//

The director of family welfare, acting on a direction from Health Minister Digamber Singh, filed complaints against the doctors with the Ashok Nagar police station of the city late Sunday.

"We have filed FIRs (first information reports) against 21 doctors working in various government and private hospitals for violating the Preconception and Prenatal Diagnostic Techniques (PCPNDT) Act," a health and family welfare department official told IANS here Monday.

"A detailed probe would be conducted in the case and all the doctors would be punished if found guilty. Female foeticide is a crime and the government plans to take effective measures to stop it in the state," Singh said.

The matter had come to light after a private TV news network exposed the doctors running a racket of female foeticide a few weeks ago.

The government was also working out the formalities to cancel the registration of those private hospitals allegedly practising female foeticide.

The minister added that a meeting of the medical advisory council will be held on May 22 to seek suggestions to strengthen the act.

--Edited IANS

Page: 1

Related medicine news :

1. Rajasthan Gears Up To Fight Against Avian Flu
2. Hot Air Balloon Festival launched in Rajasthan
3. Soft Drinks May Be Banned In Rajasthan Schools
4. Rajasthan Plans To Run Christian Institutions
5. More Than 200,000 Miners In Rajasthan Suffer From Silicosis
6. NHRC Demands Report From Govt Of Rajasthan On Sex Determination Tests
7. Residents Doctors Call Off Strike In Rajasthan
8. 72-year-old Bachelor of Rajasthan Fails Class 10 Again!
9. Rajasthan Government Plans to Monitor Private Health Centres
10. Rajasthan Government to Distribute Free Education Kits to Students
11. Rajasthan Plans to Promote Medical Tourism and Medical Education in the State
Post Your Comments:

(Date:12/1/2015)... ... ... ClinicoEconomics and Outcomes Research has published the ... ”. , As corresponding author Dr Ankita Modi says “Pre-existing gastrointestinal events may ... a large US managed care database, women aged 55 years or older with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Physicians’ Education Resource®, ... (CME), today announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will ... detection and treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Growth in ... part due to decreases in utilization of hospital and nonhospital care, according to a ... CompScope™ Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... medical images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the ... North America Annual Meeting from November 29 to December 4, 2015. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage ... (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced ... Radiological Society of North America (RSNA) 2015 annual meeting through December 3 in ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 Breg, Inc ., a premier ... that it has been awarded three contracts by Novation, ... Novation will have access to improved pricing for Breg,s ... soft goods dedicated to advancing orthopedic care.  ... U.S. population, rising prevalence of chronic conditions and the ...
(Date:12/1/2015)... , December 1, 2015 Russia ... III clinical trials. 70% of new drugs registered in Europe ... in Russia . --> Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a ...
(Date:12/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: CYTR ... oncology, today announced that it has reached its enrollment ... Phase 3 clinical trial of aldoxorubicin in patients with ... to be completed in Q1 2016. The Phase 3 trial ... Special Protocol Assessment from the FDA at 79 sites ...
Breaking Medicine Technology: